Concepedia

Kirsten Harmrolfs

KH

Statistics

Publications

29

Citations

1.9K

H-Index

21

Active since

2008

Affiliations

Helmholtz Centre for Infection Research(Current)

Helmholtz Institute for Pharmaceutical Research Saarland

Saarland University

Leibniz University Hannover

German Center for Infection Research

Kirsten Harmrolfs is an author at Helmholtz Centre for Infection Research specializing in medicinal chemistry, drug discovery, and life sciences.

ORCID

Publications per year

2008–2025

29

Publications

29

De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells

Luciana Berod, Christin Friedrich, Amrita Nandan et al. · Nature Medicine · 2014 · 899 citations

, , +14

Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity

Sascha Baumann, Jennifer Herrmann, Ritesh Raju et al. · Angewandte Chemie International Edition · 2014 · 182 citations

, , +16

Construction of a New Class of Tetracycline Lead Structures with Potent Antibacterial Activity through Biosynthetic Engineering

Urška Lešnik, Tadeja Lukežič, Ajda Podgoršek et al. · Angewandte Chemie International Edition · 2015 · 54 citations

, , +15

Anti-MRSA-acting carbamidocyclophanes H–L from the Vietnamese cyanobacterium Nostoc sp. CAVN2

Michael Preisitsch, Kirsten Harmrolfs, Hang T. L. Pham et al. · The Journal of Antibiotics · 2014 · 50 citations · Full text

, , +11

The chemistry and biology of the maytansinoid antitumor agents

Andreas Kirschning, Kirsten Harmrolfs, Tobias Knobloch · Comptes Rendus Chimie · 2008 · 48 citations

, , +11

1–5 of 29